HOME >> BIOLOGY >> NEWS
Specialized, bone-crushing wolves of Alaska disappeared long ago

The ancient gray wolves that once roamed the icy expanses of Alaska represented a specialized form that apparently died out along with other big animals at the end of the Pleistocene, many thousands of years ago, researchers report online on June 21st in the journal Current Biology, a publication of Cell Press. The extinct Alaskan wolves had robust bodies, strong jaws, and massive canine teeth for killing prey larger than themselves and regularly consuming large bones, according to the researchers.

Our results are surprising as the unique attributes of Alaskan Pleistocene wolves had not been previously recognized and show that wolves suffered an extinction at the end of the Pleistocene, said Blaire Van Valkenburgh of the University of California, Los Angeles. If not for their persistence in the Old World, we might not have wolves in North America today. Regardless, the living gray wolf differs dramatically from that which roamed Alaska just 12,000 years ago.

The gray wolf is one of the few large predators that survived the mass extinction of the late Pleistocene. Nevertheless, wolves disappeared from northern North America at that time.

To further explore the identity of Alaskas ancient wolves in the new study, the researchers collected skeletal remains of the animals from Pleistocene permafrost deposits of eastern Beringia and examined their chemical composition and genetic makeup.

Remarkably, they discovered that the late-Pleistocene wolves were distinct from existing wolves, both genetically and in terms of their physical characteristics. None of the ancient wolves were a genetic match for any modern wolves, they report. Moreover, the animals skull shape and tooth wear, as well as a chemical analysis of their bones, all suggest that eastern Beringian wolves were specialized hunters and scavengers of extinct megafauna.

The ancient wolves had relatively more massive teeth and broader skulls with shorter snouts, e
'"/>

Contact: Erin Doonan
edoonan@cell.com
617-397-2802
Cell Press
21-Jun-2007


Page: 1 2

Related biology news :

1. Presence of wolves allows aspen recovery in Yellowstone
2. Ice Age extinction claimed highly carnivorous Alaskan wolves
3. Researchers determine why wolves not dispersing as fast as expected in Yellowstone
4. Contagious cancer in dogs confirmed; origins traced to wolves centuries ago
5. Killing wolves may not protect livestock efficiently
6. Gray wolves maintain the food chain in winter
7. The lost genetic legacy of American gray wolves
8. Wolves of Alaska became extinct 12,000 years ago, scientists report
9. Academy paleontologist and Alaska artist in line for natural history awards
10. University of Alaska Fairbanks awarded $3.8M for bird flu research
11. Changing ocean conditions led to decline in Alaskas sea lion population

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Specialized bone crushing wolves Alaska disappeared long ago

(Date:10/15/2014)... increased resistance to bacterial pneumonia in female mice to ... , Females are naturally more resistant to respiratory infections ... shown that increased resistance to bacterial pneumonia in female ... 3 (NOS3). They also show that this enzyme is ... hormone estrogen. , The team, lead by Professor Lester ...
(Date:10/14/2014)... Cancer Research shows SIRT6—a protein known to inhibit ... development of skin cancers by turning on an enzyme ... cells. , Previously considered protective, SIRT6 is part of ... regulate genomic stability and prevent some of the genetic ... which can lead to cancer. This study, in the ...
(Date:10/14/2014)... October 14, 2014 – High doses of fish oil supplements, ... a common type of irregular heartbeat in which the heart ... results of the AFFORD trial led by the Montreal Heart ... College of Cardiology on October 7th. , For the ... therapy were randomly assigned to 4 grams of fish oil ...
Breaking Biology News(10 mins):Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2
(Date:10/22/2014)... 21, 2014 Shimadzu Scientific Instruments introduces ... tool for the pain management and clinical markets. The ... and review by allowing users to highlight and review ... , QuantAnalytics allows analysts to filter results by group ... processing by eliminating the need to sift through analytes ...
(Date:10/22/2014)... Hill, SC (PRWEB) October 22, 2014 ... expansion of its cardiovascular pharmacogenetics menu, which enables ... patient outcomes. With PCLS’s evidence-based results, healthcare ... needs and optimize their therapy, while minimizing risks ... In the U.S., according to the FDA [1] ...
(Date:10/22/2014)... 2014 Research and Markets  has announced ... Material, by Application, Geography - Global Analysis and Forecast ... Organic electronics, also called as polymer electronics ... which deals with small conductive molecules and electrically conductive ... and polymers are carbon based, made using synthetic strategies ...
(Date:10/20/2014)... , Oct. 20, 2014 Asterias ... the Company has signed a Notice of Grant ... Medicine (CIRM), effective October 1, 2014.  The NGA ... payments and the release of additional grant funds ... grant award for clinical development of Asterias, product, ...
Breaking Biology Technology:Shimadzu Releases QuantAnalytics Open Access LCMS Software Package for Clinical Applications 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4
Cached News: